529 related articles for article (PubMed ID: 33785807)
1. Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.
Rattay TW; Martin P; Vittore D; Hengel H; Cebi I; Tünnerhoff J; Stefanou MI; Hoffmann JF; von der Ehe K; Klaus J; Vonderschmitt J; Herrmann ML; Bombach P; Al Barazi H; Zeltner L; Richter J; Hesse K; Eckstein KN; Klingberg S; Wildgruber D
Sci Rep; 2021 Mar; 11(1):7169. PubMed ID: 33785807
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.
Endres D; Leypoldt F; Bechter K; Hasan A; Steiner J; Domschke K; Wandinger KP; Falkai P; Arolt V; Stich O; Rauer S; Prüss H; van Elst LT
Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):803-818. PubMed ID: 32166503
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder-A Retrospective Chart Review.
Campana M; Strauß J; Münz S; Oviedo-Salcedo T; Fernando P; Eichhorn P; Falkai P; Hasan A; Wagner E
Schizophr Bull; 2022 Jan; 48(1):47-55. PubMed ID: 34480476
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.
Johansson V; Jakobsson J; Fortgang RG; Zetterberg H; Blennow K; Cannon TD; Hultman CM; Wetterberg L; Landén M
Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):391-402. PubMed ID: 28039552
[TBL] [Abstract][Full Text] [Related]
5. Immunological investigations of the cerebrospinal fluid in patients with recent onset psychotic disorders: A study protocol.
Jeppesen R; Orlovska-Waast S; Vindegaard Sørensen N; Christensen RHB; Benros ME
PLoS One; 2021; 16(9):e0257946. PubMed ID: 34587214
[TBL] [Abstract][Full Text] [Related]
6. Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study.
Giné-Servén E; Martinez-Ramirez M; Boix-Quintana E; Davi-Loscos E; Guanyabens N; Casado V; Muriana D; Torres-Rivas C; Crespo-Facorro B; Labad J
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110424. PubMed ID: 34363867
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study.
Zrzavy T; Höftberger R; Wimmer I; Berger T; Rommer P; Macher S
Front Immunol; 2021; 12():646940. PubMed ID: 33828556
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis.
Sokol DK; O'Brien RS; Wagenknecht DR; Rao T; McIntyre JA
J Neuroimmunol; 2007 Oct; 190(1-2):151-6. PubMed ID: 17868908
[TBL] [Abstract][Full Text] [Related]
9. Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.
Jarius S; Haas J; Paul F; Wildemann B
J Neuroinflammation; 2019 Feb; 16(1):51. PubMed ID: 30819213
[TBL] [Abstract][Full Text] [Related]
10. Association of rheumatological markers with neuronal antibodies, cerebrospinal fluid, electroencephalography, and magnetic resonance imaging findings in 224 patients with psychotic syndromes.
Endres D; von Zedtwitz K; Nickel K; Runge K; Maier A; Domschke K; Salzer U; Prüss H; Venhoff N; van Elst LT
Brain Behav Immun; 2024 Jul; 119():482-493. PubMed ID: 38599500
[TBL] [Abstract][Full Text] [Related]
11. [An impact of the COVID-19 pandemia on the onset and course of mental disorders in elderly].
Yakovleva OB; Safarova TP; Tsvetaeva DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):131-138. PubMed ID: 37315252
[TBL] [Abstract][Full Text] [Related]
12. Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS).
Seppälä TT; Louhija UM; Appelberg B; Herukka SK; Juva K
Am J Geriatr Psychiatry; 2014 Sep; 22(9):908-16. PubMed ID: 23597931
[TBL] [Abstract][Full Text] [Related]
13. Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.
Campana M; Yakimov V; Moussiopoulou J; Maurus I; Löhrs L; Raabe F; Jäger I; Mortazavi M; Benros ME; Jeppesen R; Meyer Zu Hörste G; Heming M; Giné-Servén E; Labad J; Boix E; Lennox B; Yeeles K; Steiner J; Meyer-Lotz G; Dobrowolny H; Malchow B; Hansen N; Falkai P; Siafis S; Leucht S; Halstead S; Warren N; Siskind D; Strube W; Hasan A; Wagner E
Brain Behav Immun; 2024 Jul; 119():353-362. PubMed ID: 38608742
[TBL] [Abstract][Full Text] [Related]
14. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey.
Mancuso SG; Morgan VA; Mitchell PB; Berk M; Young A; Castle DJ
J Affect Disord; 2015 Feb; 172():30-7. PubMed ID: 25451392
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
Orlovska-Waast S; Köhler-Forsberg O; Brix SW; Nordentoft M; Kondziella D; Krogh J; Benros ME
Mol Psychiatry; 2019 Jun; 24(6):869-887. PubMed ID: 30116031
[TBL] [Abstract][Full Text] [Related]
16. High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug.
Skogh E; Sjödin I; Josefsson M; Dahl ML
J Clin Psychopharmacol; 2011 Feb; 31(1):4-9. PubMed ID: 21192135
[TBL] [Abstract][Full Text] [Related]
17. A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis.
Najjar S; Steiner J; Najjar A; Bechter K
J Neuroinflammation; 2018 Feb; 15(1):40. PubMed ID: 29433523
[TBL] [Abstract][Full Text] [Related]
18. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
19. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
[TBL] [Abstract][Full Text] [Related]
20. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.
Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
Schizophr Res; 2009 Jul; 112(1-3):80-5. PubMed ID: 19410429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
